On Tuesday, Kala Bio Inc (NASDAQ: KALA) was 7.89% up from the session before settling in for the closing price of $1.52. A 52-week range for KALA has been $1.10 – $20.60.
Annual sales at Healthcare sector company grew by 40.66% over the past five years. When this article was written, the company’s average yearly earnings per share was at 46.42%. With a float of $6.40 million, this company’s outstanding shares have now reached $6.68 million.
Kala Bio Inc (KALA) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Kala Bio Inc stocks. The insider ownership of Kala Bio Inc is 8.91%, while institutional ownership is 43.84%. The most recent insider transaction that took place on Oct 01 ’25, was worth 710,729. In this transaction Former 10% owner of this company sold 513,607 shares at a rate of $1.38, taking the stock ownership to the 46,480 shares. Before that another transaction happened on Sep 30 ’25, when Company’s Former 10% owner sold 216,801 for $1.60, making the entire transaction worth $345,993. This insider now owns 97,120 shares in total.
Kala Bio Inc (KALA) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -1.93 earnings per share (EPS) during the time that was better than consensus figure (set at -2.71) by 0.78. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.96 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 46.42% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 33.71% during the next five years compared to 40.66% growth over the previous five years of trading.
Kala Bio Inc (NASDAQ: KALA) Trading Performance Indicators
You can see what Kala Bio Inc (KALA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.10. For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.80, a number that is poised to hit -1.45 in the next quarter and is forecasted to reach -3.18 in one year’s time.
Technical Analysis of Kala Bio Inc (KALA)
Kala Bio Inc (NASDAQ: KALA) saw its 5-day average volume 1.69 million, a positive change from its year-to-date volume of 0.37 million. As of the previous 9 days, the stock’s Stochastic %D was 2.50%.
During the past 100 days, Kala Bio Inc’s (KALA) raw stochastic average was set at 2.77%, which indicates a significant decrease from 2.88% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.1499 in the past 14 days, which was higher than the 0.8765 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.5835, while its 200-day Moving Average is $6.9805. Nevertheless, the first resistance level for the watch stands at $1.7133 in the near term. At $1.7867, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.8933. If the price goes on to break the first support level at $1.5333, it is likely to go to the next support level at $1.4267. The third support level lies at $1.3533 if the price breaches the second support level.
Kala Bio Inc (NASDAQ: KALA) Key Stats
There are 7,021K outstanding shares of the company, which has a market capitalization of 11.51 million. As of now, sales total 0 K while income totals -38,510 K. Its latest quarter income was 0 K while its last quarter net income were -11,160 K.
